Abbott’s Libre 3 FDA Approved
Today, FDA updated its 510(k) website which shows that Abbott’s Libre 3 received FDA approval on Thursday, May 26, 2022. Although no Abbott press release has been observed, likely due to the US Memorial Day holiday weekend, Abbott is expected to issue a press release on Tuesday May 31 and have a full promotional booth at the upcoming ADA congress in New Orleans (June 3-7).
About The Author
Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.
If you receive our email blasts, you already have an account. Log in now
You can read the article’s full content online after purchase.